Pfizer Plans to Seek Booster Approval for 16- and 17-Year-Olds

November 30, 2021 — Pfizer and BioNTech plan to apply for FDA clearance this week for a COVID-19 booster vaccine for children ages 16 to 17. “We expect to share updates on this soon,” said Kate Longley, a spokesperson for Pfizer. Washington Post. The Food and Drug Administration can authorize an additional dose within a … Read more

Pfizer sues employee for allegedly stealing COVID vaccine secrets

Pfizer Inc. is suing a longtime employee for allegedly stealing “dozens” of confidential documents, including some related to her COVID-19 vaccine, as she was preparing to jump into a competitor. In a complaint filed Tuesday in San Diego federal court, Pfizer said Chun Xiaoli violated its confidentiality agreement by uploading more than 12,000 files without … Read more

‘Govt must exercise caution on oral anti-virals’

With India nearing potential approval of an oral antiviral drug such as Merck’s mullopiravir to treat Covid-19, health experts want the government to proceed with caution on its supplies and prices. In a sign of concern about drug resistance, if there is unrestricted use, experts suggest government authorities distribute and store these drugs more closely. … Read more

Covid-19: US opens up Covid-19 booster shots to all adults

US regulators moved on Friday to open enhanced COVID-19 footage to all adults, expanding the government’s drive to boost protections and anticipate rising coronavirus cases that could worsen with the holidays. Pfizer and Moderna announced the FDA’s decision after at least 10 states began making the boosters available to all adults. A final measure is … Read more

Pfizer claims COVID-19 pill can reduce chances of death by 89%; files for FDA approval

Pfizer Inc said Tuesday it is seeking US permission for its experimental COVID-19 antiviral pill that reduced the chance of hospitalization or death for adults at risk of serious illness by 89% in a clinical trial. Pfizer said it has completed its application for an emergency use authorization (EUA) for the drug, Paxlovid, with the … Read more

S&P hits another record high on strong jobs report, Pfizer COVID-19 pill cheer

The S&P 500 hit another record on Friday and booked a week of solid gains after a strong US jobs report and positive data for Pfizer’s trial pills against COVID-19. A Labor Department report showed employment in the United States increased more than expected in October as headwinds from an increase in COVID-19 infections ebbed … Read more

New pill against Covid-19 reduces hospital, death risk by 90%: Pfizer

Pfizer Inc said Friday that its experimental antiviral pills for Covid have reduced hospitalization and death rates by nearly 90 percent, as the drug company joins the race to bring the first easy-to-use drug against Covid to the US market. Currently, all Covid treatments used in the United States require an intravenous injection or injection. … Read more

COVID-19 vaccine booster dose effective in reducing severe outcomes: Lancet

A third dose of the COVID-19 vaccine is effective in reducing severe disease outcomes compared to individuals who received two doses at least five months earlier, according to the largest real-world study of a Pfizer booster dose published in The Lancet. The study was conducted by researchers from Clalit Research Institute and Harvard University in … Read more